We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.3B
AUM Growth
+$1.22B
Cap. Flow
-$160M
Cap. Flow %
-0.79%
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60

Top Buys

Rank Stock Value
1
TE
T1 Energy
TE
+$60.5M
2
PFE icon
Pfizer
PFE
+$44M
3
GXO icon
GXO Logistics
GXO
+$37.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31.2M
5
JD icon
JD.com
JD
+$29.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$57.2M
2
BABA icon
Alibaba
BABA
+$57.2M
3
AMRC icon
Ameresco
AMRC
+$55.4M
4
SIVB
SVB Financial Group
SIVB
+$43.1M
5
WOLF icon
Wolfspeed
WOLF
+$41.1M

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 17.92%
3 Consumer Discretionary 13.84%
4 Financials 12.09%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONL
1676
Orion Office REIT
ONL
$163M
$230K ﹤0.01%
+12,343
New +$244K
SFL icon
1677
SFL Corp
SFL
$1.62B
$230K ﹤0.01%
28,200
RXRX icon
1678
Recursion Pharmaceuticals
RXRX
$1.78B
$228K ﹤0.01%
+13,300
New +$250K
GRPN icon
1679
Groupon
GRPN
$878M
$227K ﹤0.01%
9,817
HYFM icon
1680
Hydrofarm Holdings
HYFM
$8.29M
$226K ﹤0.01%
+800
New +$271K
ACCO icon
1681
Acco Brands
ACCO
$407M
$224K ﹤0.01%
27,176
MORF
1682
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$223K ﹤0.01%
+4,700
New +$252K
HFWA icon
1683
Heritage Financial
HFWA
$1.23B
$221K ﹤0.01%
9,023
JBLU icon
1684
JetBlue
JBLU
$2.23B
$221K ﹤0.01%
15,500
NRIX icon
1685
Nurix Therapeutics
NRIX
$2.76B
$220K ﹤0.01%
+7,600
New +$230K
CSII
1686
DELISTED
Cardiovascular Systems, Inc.
CSII
$220K ﹤0.01%
11,700
SEER icon
1687
Seer Inc
SEER
$117M
$217K ﹤0.01%
+9,500
New +$274K
CBRL icon
1688
Cracker Barrel
CBRL
$1.33B
$215K ﹤0.01%
1,672
-3,000
-64% -$400K
SANA icon
1689
Sana Biotechnology
SANA
$1.12B
$215K ﹤0.01%
+13,900
New +$268K
TEVA icon
1690
Teva Pharmaceuticals
TEVA
$43.1B
$212K ﹤0.01%
26,500
SUMO
1691
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$212K ﹤0.01%
+15,600
New +$242K
MVIS icon
1692
Microvision
MVIS
$108M
$211K ﹤0.01%
+2,807
New +$335K
NTGR icon
1693
NETGEAR
NTGR
$656M
$211K ﹤0.01%
7,230
HIMS icon
1694
Hims & Hers Health
HIMS
$6.94B
$210K ﹤0.01%
+32,000
New +$231K
RCKT icon
1695
Rocket Pharmaceuticals
RCKT
$372M
$210K ﹤0.01%
9,600
DM
1696
DELISTED
Desktop Metal, Inc.
DM
$209K ﹤0.01%
+4,230
New +$285K
PTVE
1697
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$209K ﹤0.01%
16,500
VLDR
1698
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$208K ﹤0.01%
+44,800
New +$262K
ALHC icon
1699
Alignment Healthcare
ALHC
$2.83B
$207K ﹤0.01%
+14,700
New +$257K
KURA icon
1700
Kura Oncology
KURA
$977M
$207K ﹤0.01%
14,800

Similar funds

Handelsbanken Fonder's Q4 2021 Portfolio in Review

As of Q4 2021, Handelsbanken Fonder held 1,796 positions worth $20.3B, up 6.4% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Handelsbanken Fonder's Q4 2021 filing shows 121 new, 266 increased, 599 reduced and 60 closed positions. Its largest new stake was T1 Energy: 5,589,851 shares worth $62.5M. The largest sale was NVIDIA, an estimated $57.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q4 2021 buy was T1 Energy: 5,589,851 shares worth $62.5M.
  • Handelsbanken Fonder added most to Pfizer in Q4 2021, an estimated $44M increase.
  • Handelsbanken Fonder's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $57.2M.
  • Handelsbanken Fonder fully exited Acceleron Pharma in Q4 2021, selling an estimated $27.5M.
  • Handelsbanken Fonder's ten largest holdings make up 22% of its $20.3B portfolio in Q4 2021.
  • Handelsbanken Fonder opened 121 new positions and closed 60 in Q4 2021.
  • Handelsbanken Fonder's portfolio value rose 6.4% quarter-over-quarter to $20.3B.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.